Abstract
UDP-glucose 6-dehydrogenase (UGDH) produces UDP-α-D-glucuronic acid, the precursors for glycosaminoglycans (GAGs) and proteoglycans of the extracellular matrix. Elevated GAG formation has been implicated in a variety of human diseases, including glioblastoma (GBM). In our previous study, we found that Krüppel-like factor 4 (KLF4) promotes GBM cell migration by binding to methylated DNA, mainly methylated CpGs (mCpG) and transactivating gene expression. We identified UDGH as one of the downstream targets of KLF4-mCpG binding activity. In this study, we show that KLF4 upregulates UGDH expression in a mCpG-dependent manner, and UGDH is required for KLF4-induced cell migration in vitro. UGDH knockdown decreases GAG abundance in GBM cells, as well as cell proliferation and migration in vitro. In intracranial xenografts, reduced UGDH inhibits tumor growth and migration, accompanied by a decrease in the expression of extracellular matrix proteins such as tenascin C, brevican. Our studies demonstrate a novel DNA methylation-dependent UGDH upregulation by KLF4. Developing UGDH antagonists to decrease the synthesis of extracellular matrix components will be a useful strategy for GBM therapy.
References
Jul 1, 1994·Nature Genetics·J M Craig, W A Bickmore
May 30, 2003·Glycobiology·Isabelle BarbosaDulce Papy-García
Jul 2, 2004·Nature Reviews. Cancer·Bryan P Toole
Oct 7, 2004·Cancer Research·Rossella GalliAngelo Vescovi
Feb 1, 2008·Molecular Cancer Research : MCR·Thomas E ReznikJohn Laterra
Mar 6, 2009·Cell Adhesion & Migration·Jong Bae ParkSeung-Hoon Lee
Jun 27, 2009·Expert Opinion on Investigational Drugs·Cory AdamsonDarell D Bigner
Aug 19, 2010·Journal of Cellular Physiology·Claire E ClarkinAndrew A Pitsillides
Sep 25, 2010·Biochemical Society Transactions·Sigrid EggerBernd Nidetzky
Jan 19, 2011·Oncogene·F YuW Ai
Sep 16, 2011·Cold Spring Harbor Perspectives in Biology·Pengfei LuZena Werb
Feb 9, 2012·Oncogene·S D WangS Xia
Feb 16, 2012·The FEBS Journal·Nikos AfratisNikos K Karamanos
Feb 22, 2012·The Journal of Cell Biology·Pengfei LuZena Werb
Mar 3, 2012·Cancer Science·Yanjue WuShuli Xia
Jan 4, 2013·The FEBS Journal·Anna WadeJoanna J Phillips
Apr 5, 2013·Translational Oncology·Prakash RathJohn Laterra
Sep 10, 2013·ELife·Shaohui HuHeng Zhu
Mar 29, 2014·BMC Genomics·Yulia A MedvedevaUNKNOWN FANTOM consortium
Apr 9, 2014·Cancer Research·Jessica TilghmanMingyao Ying
Oct 8, 2014·The Journal of Biological Chemistry·Mingyao YingJohn Laterra
Dec 4, 2014·Arthritis Research & Therapy·Yinxian WenHui Wang
Sep 1, 2015·Neuro-oncology·Shuli XiaJohn Laterra
Nov 6, 2015·Frontiers in Oncology·Freja A VenningJanine T Erler
May 20, 2017·Current Medicinal Chemistry·Ron BatashMoshe Schaffer
May 30, 2017·ELife·Jun WanShuli Xia
Citations
Feb 23, 2019·Biomedical Research·Daisuke HagiudaYuichi Sato
Jul 17, 2019·Oncogene·James M ArnoldArun Sreekumar
Mar 23, 2019·Oncotarget·C Rory GoodwinShuli Xia
Aug 5, 2020·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Brenna M ZimmerMelanie A Simpson
Jul 11, 2020·Nature Reviews. Materials·Kayla J WolfSanjay Kumar
Feb 6, 2020·Oncogenesis·Wen-Chieh LiaoChiung-Hui Liu
Aug 29, 2018·MedChemComm·Xiaojuan XuWen Luo
Oct 24, 2018·BMC Cancer·Brian TungShuli Xia
Sep 8, 2020·Journal of Cellular and Molecular Medicine·Li-Hsun LinHong-Lin Chan
Mar 23, 2019·Cancer Research·Ding MaShuli Xia
Feb 26, 2021·Nature·Diana MahdessianEmma Lundberg
Aug 10, 2020·Cancer Letters·Shao Thing TeohSophia Y Lunt
Jun 8, 2021·Cancer Letters·Ding MaShuli Xia
Jun 15, 2021·Frontiers in Oncology·Wanyan WangJin Huang
Aug 6, 2021·Molecular Cancer Research : MCR·Daqian ZhanShuli Xia
Dec 9, 2021·Advanced Healthcare Materials·Chaitanya Tondepu, Lohitash Karumbaiah